MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-DL-11-0029777
Xenon Pharma Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹19.65 Cr
▲ 28% YoY
Net profit · FY 2024
₹79.15 Lakh
Net margin 4%
EBITDA · FY 2024
₹1.06 Cr
EBITDA margin 5.4%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Company age
21 yrs
Est. 2005
Directors on board
2
As per MCA filings
Active GSTINs
2
GST registered
About Xenon Pharma Private Limited
Data last updated:
Xenon Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 24 August 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24233DL2005PTC139951. Its GSTIN is 07AAACX0460A1ZX (Delhi). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Naresh Kumar and Karmveer Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Third Floor B – 1 635 Janakpuri, New Delhi, Delhi, India – 110058.
As per the financials filed for FY 2024, the company reported a revenue of ₹19.65 Cr, a growth of 28% compared to the previous year. For the same year it recorded a net profit of ₹79.15 Lakh (net margin 4%) and EBITDA of ₹1.06 Cr (EBITDA margin 5.4%). Revenue has grown at a compounded annual rate (CAGR) of 47% over three years and 51% over five years.
The company is associated with 1 brand: Xenon Pharmaceuticals. Court records list 6 cases involving the company, including 6 filed by the company; 3 cases are pending.
Xenon Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-11-0029777). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website xenonpharma.in.
Company details
CIN U24233DL2005PTC139951
Registration Number 139951
Incorporation Date 24 August 2005
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-DL-11-0029777
Key People
Naresh Kumar Director Karmveer Singh Director Recognitions & Rankings of Xenon Pharma
Contact details
Xenon Pharma Private Limited's registered office is in New Delhi, Delhi. Its website is xenonpharma.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressThird Floor B – 1 635 Janakpuri, New Delhi, Delhi, India – 110058
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Xenon Pharma Private Limited, buy the company report.
Comprehensive company report
Xenon Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Xenon Pharma operates one associated brand: Xenon Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Small molecule drugs against rare channelopathies are developed. | xenon-pharma.com |
Business activity
The main business activity of Xenon Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Xenon Pharma Private Limited, buy the company report.
Financials of Xenon Pharma Private Limited
FY 2025 filings availableXenon Pharma Private Limited reported revenue of ₹19.65 Cr (up 28% YoY) for FY 2024.
Revenue · FY 2024
₹19.65 Cr ▲ 28%
Net profit · FY 2024
₹79.15 Lakh margin 4%
EBITDA · FY 2024
₹1.06 Cr margin 5.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 28%
3 years · compounded
▲ 47%
5 years · compounded
▲ 51%
EBITDA CAGR growth
1 year
▲ 30%
3 years · compounded
▲ 38%
5 years · compounded
▲ 45%
Revenue has grown at a compounded annual rate (CAGR) of 51% over five years, including 28% growth in the latest year. EBITDA rose 30% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.06 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹79.15 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.4% | ||||
| Net Profit Margin | 4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Xenon Pharma Private Limited, buy the company report.
Board of directors of Xenon Pharma Private Limited
Xenon Pharma has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Naresh Kumar | Director | 19 Jan 2012 | 14 Years 9 Months | Current |
| Karmveer Singh | Director | 31 Mar 2018 | 8 Years 6 Months | Current |
Auditor
Xenon Pharma Private Limited is audited by ANIL REENU & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ANIL REENU & CO | FY 2023 | 089373 |
Shareholding
The shareholding of Xenon Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Xenon Pharma Private Limited, buy the company report.
Legal cases
Xenon Pharma Private Limited has 6 court cases on record: 6 filed by Xenon Pharma. 3 cases are pending and 3 are disposed.
Total cases
6
Filed by the company
6
Pending
3
Disposed
3
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 6 | 0 | 3 |
Cases on record (5 of 6)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Shahdara, Delhi | Commercial suit | Filed by the company against an individual | Pending |
| District court, South West, Delhi | Commercial suit | Filed by the company against an individual | Pending |
| District court, South West, Delhi | Civil suit | Filed by the company against an individual | Pending |
| District court, South West, Delhi | Court case (T. P (C)) | Filed by the company against an individual | Disposed |
| District court, South West, Delhi | Commercial suit | Filed by the company against an individual | Disposed |
To see the full case history of Xenon Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Xenon Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Xenon Pharma has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAACX0460A1ZX | Delhi | Active | 01 Jul 2017 |
| 05AAACX0460A1Z1 | Uttarakhand | Active | 16 Nov 2019 |
To see the full GST registrations and return filing status of Xenon Pharma Private Limited, buy the company report.
Recent activity
Xenon Pharma Private Limited has 8 board changes on record since 2007: 2 appointments and 6 cessations. The latest: Nikita Kukreja ceased to be Director on 02 Apr 2018.
AGM
Xenon Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Xenon Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Ceased
Nikita Kukreja ceased to be Director.
Appointed
Karmveer Singh was appointed as Director.
Ceased
Narender Kukreja ceased to be Director.
Ceased
Om Prakash Kukreja ceased to be Director.
Appointed
Naresh Kumar was appointed as Director.
Ceased
Anita Kukreja ceased to be Director.
Ceased
Shaheer Zaman Ariz ceased to be Director.
Ceased
Vikas Tyagi ceased to be Director.
Incorporation
24 Aug 2005
Xenon Pharma Private Limited was registered on 24 Aug 2005 with Roc Delhi & aged 21 years 2 months as per MCA records.
News
Frequently asked questions
Xenon Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 24 August 2005 (21+ years old) and is registered under CIN U24233DL2005PTC139951.
Xenon Pharma has 2 current directors:
- Naresh Kumar - Director
- Karmveer Singh - Director
The latest financial statements of Xenon Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Xenon Pharma is 07AAACX0460A1ZX, registered in Delhi. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 05AAACX0460A1Z1 (Uttarakhand).
The CIN (Corporate Identification Number) of Xenon Pharma is U24233DL2005PTC139951. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Xenon Pharma has 6 court cases on record: 6 filed by the company. 3 are pending.
Xenon Pharma was incorporated on 24 August 2005, making it 21+ years old. It is registered with the Registrar of Companies, Delhi.
Nikita Kukreja ceased to be Director on 02 Apr 2018. Karmveer Singh was appointed as Director on 31 Mar 2018. Narender Kukreja ceased to be Director on 25 Feb 2012. Xenon Pharma has 8 board changes on record in total.
Yes, Xenon Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-DL-11-0029777).
Xenon Pharma can be reached through the website xenonpharma.in. Its registered office is in New Delhi, Delhi, India.